Märker, D. ; Helbig, H. ; Gamulescu, M.
Alternative Links zum Volltext:DOIVerlag
Dokumentenart: | Artikel |
---|
Titel eines Journals oder einer Zeitschrift: | Klinische Monatsblätter für Augenheilkunde |
---|
Verlag: | GEORG THIEME VERLAG KG |
---|
Ort der Veröffentlichung: | STUTTGART |
---|
Band: | 229 |
---|
Nummer des Zeitschriftenheftes oder des Kapitels: | 09 |
---|
Seitenbereich: | S. 882-888 |
---|
Datum: | 2012 |
---|
Institutionen: | Medizin > Lehrstuhl für Augenheilkunde |
---|
Identifikationsnummer: | Wert | Typ |
---|
10.1055/s-0032-1314989 | DOI |
|
---|
Stichwörter / Keywords: | PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; CLINICAL CHARACTERISTICS; LASER PHOTOCOAGULATION; JAPANESE PATIENTS; RANIBIZUMAB; NEOVASCULARIZATION; ANGIOGRAPHY; FEATURES; LESION; polypoidal choroidal vasculopathy; indocyanine green angiography; photodynamic therapy; differential diagnosis of exsudative age-related macular degeneration |
---|
Dewey-Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin |
---|
Status: | Veröffentlicht |
---|
Begutachtet: | Ja, diese Version wurde begutachtet |
---|
An der Universität Regensburg entstanden: | Ja |
---|
Dokumenten-ID: | 63411 |
---|
Web of Science
Zusammenfassung
Polypoidal choroidal vasculopathy (PCV) is a disease that was first described almost 30 years ago. The disease is characterised by alterations of the posterior pole such as serous or serosanguineous detachments of the retina or the retinal pigment epithelium (RPE) around the optic nerve or in the central macula. The optimal therapeutic regime remains unclear. There are several studies suggesting ...
Zusammenfassung
Polypoidal choroidal vasculopathy (PCV) is a disease that was first described almost 30 years ago. The disease is characterised by alterations of the posterior pole such as serous or serosanguineous detachments of the retina or the retinal pigment epithelium (RPE) around the optic nerve or in the central macula. The optimal therapeutic regime remains unclear. There are several studies suggesting that patients who do not respond satisfactorily to intravitreal anti-VEGF treatment are suffering from PCV which can be detected by indocyanine green angiography. Alternative therapeutic options consist of photodynamic therapy or laser photocoagulation for extrafoveal lesions.